nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CTSV—nephron tubule—nephrolithiasis	0.0368	0.0919	CbGeAlD
Boceprevir—CTSV—renal system—nephrolithiasis	0.0335	0.0835	CbGeAlD
Boceprevir—CTSV—kidney—nephrolithiasis	0.0324	0.0807	CbGeAlD
Boceprevir—CTSV—cortex of kidney—nephrolithiasis	0.0315	0.0786	CbGeAlD
Boceprevir—Cardiac murmur—Hydrochlorothiazide—nephrolithiasis	0.0313	0.0523	CcSEcCtD
Boceprevir—CTSL—nephron tubule—nephrolithiasis	0.0301	0.075	CbGeAlD
Boceprevir—CTSL—renal system—nephrolithiasis	0.0273	0.0682	CbGeAlD
Boceprevir—CTSL—kidney—nephrolithiasis	0.0264	0.0659	CbGeAlD
Boceprevir—CTSL—cortex of kidney—nephrolithiasis	0.0257	0.0642	CbGeAlD
Boceprevir—CTSK—renal system—nephrolithiasis	0.0206	0.0514	CbGeAlD
Boceprevir—CTSK—kidney—nephrolithiasis	0.0199	0.0497	CbGeAlD
Boceprevir—Joint swelling—Hydrochlorothiazide—nephrolithiasis	0.0198	0.0331	CcSEcCtD
Boceprevir—CYP3A4—urine—nephrolithiasis	0.0184	0.0459	CbGeAlD
Boceprevir—CTSS—renal system—nephrolithiasis	0.018	0.045	CbGeAlD
Boceprevir—CTSS—kidney—nephrolithiasis	0.0174	0.0435	CbGeAlD
Boceprevir—CTSS—cortex of kidney—nephrolithiasis	0.017	0.0424	CbGeAlD
Boceprevir—Encephalopathy—Hydrochlorothiazide—nephrolithiasis	0.0151	0.0253	CcSEcCtD
Boceprevir—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.0124	0.0207	CcSEcCtD
Boceprevir—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0179	CcSEcCtD
Boceprevir—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0175	CcSEcCtD
Boceprevir—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0175	CcSEcCtD
Boceprevir—Gout—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0174	CcSEcCtD
Boceprevir—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0169	CcSEcCtD
Boceprevir—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.00989	0.0165	CcSEcCtD
Boceprevir—Musculoskeletal pain—Hydrochlorothiazide—nephrolithiasis	0.00983	0.0164	CcSEcCtD
Boceprevir—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.00943	0.0157	CcSEcCtD
Boceprevir—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00815	0.0136	CcSEcCtD
Boceprevir—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00811	0.0135	CcSEcCtD
Boceprevir—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00796	0.0133	CcSEcCtD
Boceprevir—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.00774	0.0129	CcSEcCtD
Boceprevir—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.00747	0.0125	CcSEcCtD
Boceprevir—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00744	0.0124	CcSEcCtD
Boceprevir—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00726	0.0121	CcSEcCtD
Boceprevir—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00705	0.0118	CcSEcCtD
Boceprevir—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00694	0.0116	CcSEcCtD
Boceprevir—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00694	0.0116	CcSEcCtD
Boceprevir—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00668	0.0111	CcSEcCtD
Boceprevir—CYP3A5—nephron tubule—nephrolithiasis	0.00659	0.0165	CbGeAlD
Boceprevir—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00646	0.0108	CcSEcCtD
Boceprevir—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.00644	0.0107	CcSEcCtD
Boceprevir—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00642	0.0107	CcSEcCtD
Boceprevir—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00637	0.0106	CcSEcCtD
Boceprevir—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00624	0.0104	CcSEcCtD
Boceprevir—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00622	0.0104	CcSEcCtD
Boceprevir—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00614	0.0102	CcSEcCtD
Boceprevir—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00609	0.0102	CcSEcCtD
Boceprevir—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00609	0.0102	CcSEcCtD
Boceprevir—CYP3A5—renal system—nephrolithiasis	0.00599	0.015	CbGeAlD
Boceprevir—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00598	0.00997	CcSEcCtD
Boceprevir—CYP3A5—kidney—nephrolithiasis	0.00579	0.0145	CbGeAlD
Boceprevir—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.0057	0.00951	CcSEcCtD
Boceprevir—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.0057	0.00951	CcSEcCtD
Boceprevir—CYP3A5—cortex of kidney—nephrolithiasis	0.00564	0.0141	CbGeAlD
Boceprevir—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00563	0.0094	CcSEcCtD
Boceprevir—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00561	0.00937	CcSEcCtD
Boceprevir—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00556	0.00928	CcSEcCtD
Boceprevir—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.0055	0.00917	CcSEcCtD
Boceprevir—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00547	0.00912	CcSEcCtD
Boceprevir—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00539	0.00899	CcSEcCtD
Boceprevir—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00533	0.00889	CcSEcCtD
Boceprevir—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00528	0.00881	CcSEcCtD
Boceprevir—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00528	0.00881	CcSEcCtD
Boceprevir—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00513	0.00855	CcSEcCtD
Boceprevir—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.0051	0.00851	CcSEcCtD
Boceprevir—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00507	0.00846	CcSEcCtD
Boceprevir—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00489	0.00816	CcSEcCtD
Boceprevir—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00485	0.0081	CcSEcCtD
Boceprevir—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00484	0.00808	CcSEcCtD
Boceprevir—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00481	0.00802	CcSEcCtD
Boceprevir—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.0047	0.00785	CcSEcCtD
Boceprevir—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00461	0.0077	CcSEcCtD
Boceprevir—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00455	0.00759	CcSEcCtD
Boceprevir—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00453	0.00756	CcSEcCtD
Boceprevir—CYP3A4—renal system—nephrolithiasis	0.0045	0.0112	CbGeAlD
Boceprevir—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00436	0.00727	CcSEcCtD
Boceprevir—CYP3A4—kidney—nephrolithiasis	0.00435	0.0109	CbGeAlD
Boceprevir—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00431	0.00719	CcSEcCtD
Boceprevir—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00425	0.00709	CcSEcCtD
Boceprevir—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00418	0.00698	CcSEcCtD
Boceprevir—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00416	0.00694	CcSEcCtD
Boceprevir—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00411	0.00685	CcSEcCtD
Boceprevir—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00408	0.00681	CcSEcCtD
Boceprevir—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.004	0.00668	CcSEcCtD
Boceprevir—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00394	0.00658	CcSEcCtD
Boceprevir—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00392	0.00655	CcSEcCtD
Boceprevir—Agitation—Hydrochlorothiazide—nephrolithiasis	0.0039	0.00651	CcSEcCtD
Boceprevir—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00388	0.00648	CcSEcCtD
Boceprevir—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00383	0.00639	CcSEcCtD
Boceprevir—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00382	0.00637	CcSEcCtD
Boceprevir—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00381	0.00636	CcSEcCtD
Boceprevir—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.0038	0.00634	CcSEcCtD
Boceprevir—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00375	0.00626	CcSEcCtD
Boceprevir—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00373	0.00623	CcSEcCtD
Boceprevir—Cough—Hydrochlorothiazide—nephrolithiasis	0.00371	0.00618	CcSEcCtD
Boceprevir—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00362	0.00603	CcSEcCtD
Boceprevir—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00362	0.00603	CcSEcCtD
Boceprevir—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00362	0.00603	CcSEcCtD
Boceprevir—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.0036	0.00601	CcSEcCtD
Boceprevir—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00357	0.00596	CcSEcCtD
Boceprevir—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00354	0.0059	CcSEcCtD
Boceprevir—ABCB1—nephron tubule—nephrolithiasis	0.0035	0.00874	CbGeAlD
Boceprevir—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00349	0.00583	CcSEcCtD
Boceprevir—Shock—Hydrochlorothiazide—nephrolithiasis	0.00341	0.00569	CcSEcCtD
Boceprevir—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00339	0.00566	CcSEcCtD
Boceprevir—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00338	0.00564	CcSEcCtD
Boceprevir—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00335	0.00559	CcSEcCtD
Boceprevir—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00324	0.0054	CcSEcCtD
Boceprevir—ABCB1—renal system—nephrolithiasis	0.00318	0.00794	CbGeAlD
Boceprevir—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00316	0.00527	CcSEcCtD
Boceprevir—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00313	0.00523	CcSEcCtD
Boceprevir—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00311	0.00519	CcSEcCtD
Boceprevir—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00309	0.00516	CcSEcCtD
Boceprevir—ABCB1—kidney—nephrolithiasis	0.00308	0.00768	CbGeAlD
Boceprevir—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00305	0.00509	CcSEcCtD
Boceprevir—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00301	0.00503	CcSEcCtD
Boceprevir—ABCB1—cortex of kidney—nephrolithiasis	0.003	0.00748	CbGeAlD
Boceprevir—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00299	0.00499	CcSEcCtD
Boceprevir—Pain—Hydrochlorothiazide—nephrolithiasis	0.00296	0.00495	CcSEcCtD
Boceprevir—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00296	0.00495	CcSEcCtD
Boceprevir—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00286	0.00477	CcSEcCtD
Boceprevir—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00283	0.00473	CcSEcCtD
Boceprevir—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00275	0.00459	CcSEcCtD
Boceprevir—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00274	0.00457	CcSEcCtD
Boceprevir—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00274	0.00457	CcSEcCtD
Boceprevir—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00255	0.00426	CcSEcCtD
Boceprevir—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00249	0.00415	CcSEcCtD
Boceprevir—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00245	0.00409	CcSEcCtD
Boceprevir—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00237	0.00396	CcSEcCtD
Boceprevir—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00229	0.00382	CcSEcCtD
Boceprevir—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.0022	0.00368	CcSEcCtD
Boceprevir—Rash—Hydrochlorothiazide—nephrolithiasis	0.00219	0.00365	CcSEcCtD
Boceprevir—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00218	0.00364	CcSEcCtD
Boceprevir—Headache—Hydrochlorothiazide—nephrolithiasis	0.00217	0.00362	CcSEcCtD
Boceprevir—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00206	0.00344	CcSEcCtD
